Publications dans lesquelles il/elle collabore avec Abdelkrim Hmadcha Afif (41)

2024

  1. Antibiotic discovery with artificial intelligence for the treatment of Acinetobacter baumannii infections

    mSystems, Vol. 9, Núm. 6

2023

  1. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  2. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

  3. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. Considerations for Clinical Use of Mesenchymal Stromal Cells

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102

  2. Pdx1 Is Transcriptionally Regulated by EGR-1 during Nitric Oxide-Induced Endoderm Differentiation of Mouse Embryonic Stem Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

2021

  1. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

  2. Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr−/−.Leiden mice without attenuation of steatohepatitis

    Scientific Reports, Vol. 11, Núm. 1

  3. Stemness of human pluripotent cells: Hypoxia-like response induced by low nitric oxide

    Antioxidants, Vol. 10, Núm. 9

  4. miR-21 mimic blocks obesity in mice: A novel therapeutic option

    Molecular Therapy - Nucleic Acids, Vol. 26, pp. 401-416

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  2. Dissecting the brain/islet axis in metabesity

    Genes, Vol. 10, Núm. 5

  3. Extra virgin olive oil diet intervention improves insulin resistance and islet performance in diet-induced diabetes in mice

    Scientific Reports, Vol. 9, Núm. 1

  4. Human mesenchymal stem cells prevent neurological complications of radiotherapy

    Frontiers in Cellular Neuroscience, Vol. 13

  5. Inadequate control of thyroid hormones sensitizes to hepatocarcinogenesis and unhealthy aging

    Aging, Vol. 11, Núm. 18, pp. 7746-7779

  6. Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells

    Diabetologia, Vol. 62, Núm. 9, pp. 1667-1680

  7. Stem Cells: Concept, Properties, and Characterization

    CORNEAL REGENERATION: THERAPY AND SURGERY (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 41-55

2018

  1. PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients

    Molecular Therapy, Vol. 26, Núm. 11, pp. 2696-2709

  2. miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation

    Molecular Therapy - Nucleic Acids, Vol. 12, pp. 463-477